Minimal residual disease and relapse surveillance in osteosarcoma: an action-linked framework integrating liquid biopsy and imaging biomarkers
Guoli Huang, Yang Zhou, Hao Wang, Xiucai Ma · 2026
Read Minimal residual disease and relapse surveillance in osteosarcoma: an action-linked framework integrating liquid biopsy and imaging biomarkers by Guoli Huang, Yang Zhou, Hao Wang, Xiucai Ma (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13628598.txt.
Description
Guoli Huang, Yang Zhou, Hao Wang, and Xiucai Ma review relapse surveillance in osteosarcoma in a 2026 paper. This bone cancer often returns in the lungs or at the first site. Care now rests on scheduled imaging, since salvage treatment needs anatomic proof of return. Yet disease can be active before scans can locate it. The review reframes surveillance as a decision workflow tied to actions.
Blood tests for tumor DNA give the strongest residual disease signal so far, sometimes flagging return before imaging. Other blood signals remain exploratory. Imaging stays essential for locating disease and planning treatment. The authors propose pathways for each mix of blood and imaging results. Readers see biomarkers as triggers for reassessment, not replacements for scans.
Catalog record
| CREATOR | Guoli Huang, Yang Zhou, Hao Wang, Xiucai Ma |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 64 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |